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Abstract—Diabetes (Diabetes mellitus) is a metabolic disease 
that occurs either when the pancreas does not produce enough 
insulin to regulate blood sugar or when the body itself cannot 
effectively use the insulin it produces, it leads to increased 
concentration of glucose in the blood. The most advanced 
glucose meter module available in the market does not have the 
capability to create a profile for multiple users and save the test 
readings they make.  In this study, a glucose meter module is 
modified to effectively store blood glucose reading under a 
user’s profile for blood glucose monitoring purposes.  After the 
reading has been completed, a pop-up window will appear which 
will show the user the recommended starting dose based on the 
weight and condition of the user.  The accuracy of the device in 
providing glucose reading is similar to the ones available in the 
market since the researchers used a commercially available 
glucose meter modules and innovated it to do additional 
functions 
 




Diabetes affects 347 million people worldwide and is one of 
the leading causes of death and World health organization 
expects it to increase by 50 % over the next ten years [1]. It is 
projected that by the year 2030, diabetes will be the seventh 
leading cause of death among people worldwide [1]. In the 
Philippines alone, more than 4 million people were recorded 
to have diabetes. The Department of Health’s statistics shows 
that in 2009, the disease was number 8 out of the ten leading 
causes of mortality [2]. 
Being able to monitor blood glucose is essential to a 
diabetic patient, this made way for the development of 
glucose meter modules [3]. The most advanced glucose meter 
modules are the Bayer’s Contour Glucose Meter that has the 
capability to measure blood sugar level and can store up to 
2000 data and the Abbott Diabetes Care Freestyle Insulinx 
can compute for insulin dosage and even transmit data to 
other devices via wireless connections and can hold up to 
3000 data [3]. In addition, there have been reports of glucose 
meters based for single-handed use with internal strip storage 
[4], StatStrip based glucose meter [5], protective smartphone 
case based glucose meter [6] and stretchable glucose meter 
[7]. 
However, glucose meter modules with insulin dosage 
recommendation that are commercially available are 
incapable of separating and storing data for different users 
under a single device to test blood sugar level. 
The study aims to develop a glucometer with insulin dosage 
recommendation function for multiple users.   Specifically, to 
test our developed glucometer which measures blood sugar 
that has multiple user features and compare results with a 
commercial glucometer.   Furthermore, the study will create 
a program that calculates insulin dosage recommendation. 
The glucose meter’s basic function and profiling for 
multiuser features can be used by anyone including non-
diabetic patients but insulin dosage recommendation is 
limited to type 2 diabetic patients who are using Sanofi-
Aventus’ Lantus Insulin Glargine.  The study is limited to 
Sanofi Diabetes’ Dosing and titration options for basal and 
prandial insulin (Basal insulin dosing options for hospitalized 
diabetes patients is used a reference in calculating the 
recommended starting dose). The projected increment 
/decrement dosage shot units will be based on their sliding 
scale. Dosing recommendation will be based on the condition 
of the patient and weight. The options available for ‘patient’s 
condition’ are Diabetic obese, Diabetic with the risk of 
hypoglycemia, and Diabetic without other special 
considerations (without other complications) [8]. The 
“Normal” selection is the option available for non-insulin 
diabetic patients who opt to use the device.   The study does 
not cover recommendations for users who are injecting other 
insulin type other than Sanofi-Aventus’ Lantus Insulin 
Glargine. The device can accommodate multiple users and 
store a large amount of data.  The device is only capable of 
measuring glucose level and computing recommended 
insulin dosage based on the provided information (The 
patient will declare whether he is, normal, obese, with the risk 




The inputs for the system are the diabetic patient’s name, 
weight (kg) and other conditions such as (1) Normal for non-
diabetic users; (2) Diabetic with Risk of Hypoglycemia; (3) 
Diabetic without special considerations (without other 
complications); and (4) Diabetic Obese. The prototype is 
composed of three major components: the glucometer (True 
Result) which will provide the blood sugar reading in mg/dL, 
Real Time Clock and the Raspberry Pi 1 Model B for the 
Graphical User Interface of the prototype. 
Gambas 3.6.2 would be the software used to program the 
Graphical User Interface (GUI) of the prototype. The 
researchers can only use the True Result test strip which will 
be inserted in the device. A blood sample will then be placed 
on the test strip when the “Test Strip Ready” shows in the 
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screen. After the device read the sample, it will give us the 
Blood Sugar Reading (mg/dL) and the Insulin Dosage 
Recommended (units) [10]. The conceptual framework of 
this work is illustrated in Figure 1. 
Figure1: Conceptual Framework 
 
A. Research about glucose meter modules and choose 
one 
The researchers used Nipro’s TrueResult glucose meter 
module to develop. Thus, the purchased Nipro’s True Result 
glucose meter module was dismantled and modified for the 
application of this work. The module requires no coding, can 
store 500 tests in its memory and other key features, making 
it ideal for further development too. 
B. Analyze the glucose meter module’s (True Result) 
LCD 
The first thing that was done is to know the signals 
generated by the glucose meter to its LCD so that the signals 
can be analyzed with each pin having connecting wires.With 
the aid of PicKit 3 and a voltage supply of 3V, an alternating 
square wave was read with 10ms per pulse or 20ms period 
which has 50Hz frequency and 50% duty cycle for each pin. 
Based on the logic analyzer, it was found out that Pins 7-10 
are the selectors who have multiplex signals.   Pins 1 and 25 
are grounded and pins 2-6 and 11-24 are the signals that turn 
on the specific segments of the LCD. The LCD will only turn 
on when the bit (1-15) is high prior to the trigger and the bit 
(1-15) is low when the trigger (A, B, C, D) is high. A PWM 
generator was connected to the glucometer’s LCD with a 
pull-down resistor to emulate the glucose meter module’s 
behavior concerning the signals it sends to the LCD. The 
signal generator was used to make a square wave to run the 
glucose meter module and having each signal pins (Pins 2-6 
and 11-25) in a pull-down manner for the signal to be reset to 
0. Since a square wave was generated by the signal, an 
inverter IC was used to create an inverted signal for the signal 
pins in order to turn on the segments in the LCD. With these, 
we were able to determine which pin pair will activate the 
segments in the LCD. At first all the segments in the LCD are 
lit. By continuously testing for which Selector Pins and 
Signal Pins are assigned for the insert test strip, and the multi-
segment displays (blood sugar reading values), a character 
map was made. 
C. Integration of glucose meter module’s LCD and RTC 
with the Raspberry Pi 
Raspbian Wheezy is the OS or Image file we downloaded 
onto the SD card that also has the programming software that 
we used, the Gambas 3.6.2.After setting up the Raspberry Pi, 
we integrated the glucometer’s LCD and the RTC to the 
GPIO pins of the raspberry pi as shown in Figure 2. Using 
Gamba's inputs, we collected the data that the glucometer 
provides to the LCD when it turns on. Then, we acquired the 
states of the segments in the LCD when the selector pins A, 
B, C and D were in an “on” state. Then, codes and running 
codes were assigned to every significant data segment to 
every LCD pins needed to read the blood sugar reading. After 
the codes were assigned, we programmed the Graphical User 
Interface (GUI) for the user's profile and for it to be able to 
get the Blood Sugar Reading from the Glucose meter’s LCD 
and program the Insulin Sliding Scale for the Insulin Dosage 
Recommendation of our device. The schematic of the 













Figure 2: (a) Glucometer’s LCD integrated to Raspberry Pi, (b) GPIO of 















Figure 3: Multi-User Glucose Meter with Insulin Dosage Recommendation 
Circuit Connection 
D. Implementation 
The program and GUI were created in raspberry pi via 
Gambas version 3.6.2. In order to assure that the two devices 
will produce reliable results, glucose solution was used to 
both devices before proceeding to an actual blood test, the 
sugar reading should match or at least very close in value. 














Figure 4: (a) Prototype vs (b) Glucose Meter Glucose Solution Reading 
E. Prototype system flow 
The course of the system as a user navigates the device 
from start to finish is shown in Figure 5. Once the program 
(a) (b) 
(a) (b) 
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has started, the guest has the option to select his existing 
profile or to create a new profile.  If the guest opts to create a 
new profile, he will be asked to input his name, weight and 
condition so that the program can calculate the guest’s 
starting insulin dose. After saving this information in the 
system, the guest shall set his profile. The monitor will 
display a “No Strip Found” message indicating that you 
should insert a test strip.  After feeding the device a test strip, 
it will initialize the strip and once completed, the monitor 
shall display “Test Strip Ready”. The user should provide a 
sample of his blood to the allotted blood slot on the test strip. 
The program will process the information and shall display 
the user’s random blood glucose reading onto the monitor. 
The user may just press “ok” if he wants to conduct another 



















Figure 5: System Flow Chart 
F. Research about diabetes and its basis of insulin 
dosing 
There are three general types of diabetic patients based on 
the abridged prescribing information of Lantus. 1.  Diabetic 
with Risk of Hypoglycemia (such as patients with renal or 
hepatic dysfunction, elderly, etc), 2. Diabetic without special 
consideration, and 3.Diabetic Obese.  The device will 
recommend a basal insulin starting dose (0.3, 0.5 and 0.7 
units/kg) depending on the patient type and weight. If the 
patient is a non-diabetic person, there will be no 
recommended insulin. Identify medical standards used in 
dosing insulin and know its formula [4]. First step is to 
compute the starting dose based from the Sanofi Diabetes’ 
Dosing and titration options for basal and prandial insulin 
(Basal insulin dosing options for hospitalized diabetes 
patients is used a reference in calculating the recommended 
starting dose). The next step depends on his blood sugar 
reading. To compute for the starting dose, we need the 
diabetic patient’s weight to be multiplied to a certain 
multiplier for each condition in the prototype which is shown 
in Table 1. 
Table 1 
Dosing Based on Diabetic Patient Type and Weight 
 
Basal Insulin Dose mmol/mol 
0.3 units/kg Conditions with the risk of hypoglycemia 
0.5 units/kg Patients without special considerations 
0.7 units/kg Obese 
 
After obtaining the starting dose, increments/decrements 
will be added / subtracted from the starting dose depending 
on the blood sugar reading of the user. The formula for the 
Insulin Dosage Recommended by the prototype would be: 
A= B+C  (1) 
where A is insulin dosage recommended by the prototype 
which is  the final dose given by the prototype,B is starting 
dose which is the initial amount of insulin dose to be 
increment/decrement by the dose change in the sliding scale 
and C is dose change which is increment/decrement dose 
change in the starting dose dependent on blood sugar reading 
The sliding scale is based on the published Journal of 
Diabetes Science and Technology, Initiation and 
Maintenance Phase Minimum Dosing Titration Algorithms 
shown in Table 2. 
 
Table 2 
Insulin Dose Adjustment Algorithm 
 
Insulin glargine 
Plasma equivalent glucose values 
mg/dl mmol/liter Dose change 
<80 <4.4 -2 units 
80 - 100 4.4-5.5 0 
101-120 5.6-6.7 +2 units 
121-140 6.8-7.8 +4 units 
141-160 7.9-8.9 +6 units 
>160 >8.9 +8 units 
 
III. RESULT AND DISCUSSION 
 
To establish the accuracy of the blood glucose reading 
provided by the prototype, we have used several glucose 
control solutions of different known concentration as the 
prototype and the glucose meter module specimen. The 
Prototype vs. Glucose Meter Module using Glucose 
Concentration accuracy is 97.26% and the data summary is 
shown in Figure 6. 
Meanwhile, to check the accuracy of the provided insulin 
(glargine) recommended dose of the device based on the 
condition of each user (multi conditions), it was actually 
tested by diabetic patients that uses the specific insulin and 
the result is further compared to the glucose meter module 
reading and the doctor's recommended insulin dose. Each 
patient has a different condition such as (1) Normal for non-
diabetic users; (2) Diabetic with Risk of Hypoglycemia; (3) 
Diabetic without special consideration (without other 
complications); and (4) Diabetic Obese. The overall accuracy 
of the Prototype vs. Glucose Meter Module using Blood 
Sample is 96.97% while it's accuracy in recommending 
insulin is 89.00% as shown in the result summary in Figure 
7. The accuracy calculation was adapted based on the method 
shown in the study done by  Zhu [11] and the formula can be 
referred to the study by Zhu [11] and it will not be discussed 
here.  
A sample T-test was done based on Ho(null hypothesis): 
There is no difference in the blood sugar reading provided by 
the glucose meter modules and the prototype. For Patient A 
data is done and the module prescribed insulin dosage and the 
data from the prototype has no critical difference. It confirms 
no statistical difference in the blood sugar reading of a 
glucose meter module and the prototype. Summary found in 
Table 3.The t-stat value was utilized as the t-statistic is the 
ratio of the departure of the estimated value of a parameter 
from its hypothesized value to its standard error. 
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Patient A: Diabetic Risk of Hypoglycemia 
Items Module Prototype 
Mean 102.2 101.2 
Variance 68.7 69.7 
Observations 5 5 




df 8  
t Stat 0.19007148  
P(T<=t) one-tail 0.426993741  
t Critical one-tail 1.859548038  
P(T<=t) two-tail 0.853987482  
t Critical two-tail 2.306004135  
 
Thus based on the results in Table 3, shows that we cannot 
reject null hypothesis because t Stat is less than t Critical one-
tail ( 0.1901<1.8595 ). Blood sugar reading results in module 
and prototype for patient A who is a diabetic risk of 
hypoglycemia shows no difference. Table 4 shows the results 
for Patient B,normal. Based on Table 4, shows that we cannot 
reject null hypothesis because t Stat is less than t Critical one-
tail ( 0.1129<1.8595 ). Blood sugar reading results in module 




























Patient B: Normal 
Items Module Prototype 
Mean 98.4 97.6 
Variance 133.3 117.8 
Observations 5 5 




df 8  
t Stat 0.112889002  
P(T<=t) one-tail 0.456449971  
t Critical one-tail 1.859548038  
P(T<=t) two-tail 0.912899942  
t Critical two-tail 2.306004135  
 
Table 5 shows the results for Patient C , Diabetic Obese.  
Based on the results in Table 5, it shows that it cant reject null 
hypothesis because t Stat is less than t critical one-tail ( 
0<1.8595 ). Blood sugar reading results in module and 
prototype for patient C who is obese diabetic shows no 
difference. 
Table 6 shows the results for Patient D, Diabetic without 
special consideration.  Based on the results in Table 6, it 
shows that it does reject null hypothesis because t Stat is less 
than t critical one-tail ( -0.0904<1.8595 ). Blood sugar 
reading results in module and prototype for patient D who is 





Figure 6: Prototype vs. Glucose Meter Module using Glucose Concentration results 
Figure 7: Prototype vs. Glucose Meter Module using Blood Sample 
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Table 5 
Patient C: Diabetic Obese 
Items Module Prototype 
Mean 107 107 
Variance 147.5 176.5 
Observations 5 5 




df 8  
t Stat 0  
P(T<=t) one-tail 0.5  
t Critical one-tail 1.859548038  
P(T<=t) two-tail 1  
t Critical two-tail 2.306004135  
 
Table 6 
Patient D: Diabetic without Special Consideration 
Items Module Prototype 
Mean 109.2 109.6 
Variance 32.7 65.3 
Observations 5 5 




df 8  
t Stat -0.09035079  
P(T<=t) one-tail 0.465114825  
t Critical one-tail 1.859548038  
P(T<=t) two-tail 0.930229651  




The researchers were successful in enhancing a glucose 
meter module by adding user profiling and insulin dosage 
recommendation functions. Under each profile, user 
information such as name, weight, condition, blood sugar 
reading can be saved to a user profile.  The device is 97.26% 
accurate in comparison to the prototype and the module. The 
device does recommend the starting dose of a user, which is 
dependent on the patient’s blood sugar reading and weight.  
Any adjustment in the dosing titration shall follow Lantus 
outpatient dosing recommendations.   Several trials were 
made for each patient type namely (1) Diabetic with risk of 
hypoglycemia; (2) Diabetic obese; (3) Diabetic without 
special considerations/complications; (4) Normal (non-
diabetic); The overall accuracy of the prototype vs. Glucose
 Meter Module using Blood Sample is 96.97% while it's 
accuracy in recommending insulin is 89.00%.  T-test two-
sample assuming equal variance confirms that the means of 
the doctor’s prescribed insulin dosage and the data given by 
the prototype has no statistical difference. T-test also 
confirms no statistical difference in the blood sugar reading 
of a glucose meter module and the prototype.  Moreover, 
users can create their own profile without mixing their 
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